{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T01:33:01Z","timestamp":1770082381554,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000950","name":"Cancer Council South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008719","name":"Movember Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001787","name":"University of South Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Prostate cancer is a common malignancy in men, with radical prostatectomy (RP) being a major treatment option. This study investigates post-prostatectomy rehospitalisation rates and risk factors in a cohort of South Australian men who underwent RP from 2002 to 2021 (n\u2009=\u20095105).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Post-prostatectomy rehospitalisation rates at 30 and 90 days were measured from hospital discharge data, with reasons determined from ICD-10 codes. Rates per 1000 person-time were estimated, accounting for the length of follow-up. Zero inflated negative binomial regression analyses were used to identify sociodemographic and clinical factors associated with the number of hospital encounters following RP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Approximately 13% of patients had at least one hospital visit within 90 days post-prostatectomy. Common reasons for early rehospitalisation (within 30 days) were urinary obstruction (3.2%), haematuria (2.6%), and urinary tract infection (2.5%). Older age (aged 75\u2009+\u2009vs\u2009&lt;\u200960: incidence rate ratio (IRR) 2.23, 95% CI: 1.88\u20132.64), highest comorbidity burden (3\u2009+\u2009vs 0: IRR 2.33, 95% CI: 1.80\u20133.01), and high risk clinical characteristics (PSA\u2009&gt;\u200920 vs\u2009&lt;\u200910\u00a0ng\/mL: IRR 1.67, 95% CI: 1.34\u20132.08 and Gleason score 9\u201310 vs\u2009&lt;\u20097: IRR 1.39, 95% CI: 1.06\u20131.84) were associated with higher rehospitalisation rates. Conversely, men who were treated from 2016\u20132021 had 39% lower rehospitalisation rates (IRR 0.61, 95% CI: 0.53\u20130.71) compared with patients treated from 2002\u20132005.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings highlight the importance of considering patient characteristics and tailoring post-surgical care plans to minimise rehospitalisation. The reduction in rehospitalisation over time may reflect advancements in surgical techniques, better patient selection or improved surgeon experience.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11255-025-04691-z","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T14:29:04Z","timestamp":1753453744000},"page":"527-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-prostatectomy rehospitalisation rates and risk factors in South Australian men with prostate cancer: evidence from linked data"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-3426","authenticated-orcid":false,"given":"Tenaw","family":"Tiruye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Jay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesel M.","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Roder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerri","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"4691_CR1","unstructured":"Australian Institute of Health and Welfare. Cancer data in Australia (2024) [https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia\/contents\/overview. Accessed 15 Aug 2024."},{"issue":"1","key":"4691_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/bco2.288","volume":"5","author":"T Tiruye","year":"2024","unstructured":"Tiruye T, O\u2019Callaghan M, Ettridge K, Moretti K, Jay A, Higgs B et al (2024) Clinical and functional outcomes for risk-appropriate treatments for prostate cancer. BJUI Compass 5(1):109\u2013120","journal-title":"BJUI Compass"},{"key":"4691_CR3","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","volume":"375","author":"JL Donovan","year":"2016","unstructured":"Donovan JL, Hamdy FC, Lane J, Mason M, Metcalfe C, Walsh E et al (2016) Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med 375:1425\u20131437","journal-title":"N Engl J Med"},{"issue":"1","key":"4691_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12894-022-01117-1","volume":"22","author":"T Tiruye","year":"2022","unstructured":"Tiruye T, O\u2019Callaghan M, Moretti K, Jay A, Higgs B, Santoro K et al (2022) Patient-reported functional outcome measures and treatment choice for prostate cancer. BMC Urol 22(1):169","journal-title":"BMC Urol"},{"issue":"3","key":"4691_CR5","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.euo.2023.12.007","volume":"7","author":"C Corsini","year":"2024","unstructured":"Corsini C, Bergengren O, Carlsson S, Garmo H, Hjelm-Eriksson M, Fransson P et al (2024) Patient-reported side effects 1 year after radical prostatectomy or radiotherapy for prostate cancer: a register-based nationwide study. Eur Urol Oncol 7(3):605\u2013613","journal-title":"Eur Urol Oncol"},{"key":"4691_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4817","volume":"339","author":"DP Smith","year":"2009","unstructured":"Smith DP, King MT, Egger S, Berry MP, Stricker PD, Cozzi P et al (2009) Quality of life three years after diagnosis of localised prostate cancer: population based cohort study. BMJ 339:b4817","journal-title":"BMJ"},{"issue":"11","key":"4691_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1001\/jama.2017.1704","volume":"317","author":"DA Barocas","year":"2017","unstructured":"Barocas DA, Alvarez J, Resnick MJ, Koyama T, Hoffman KE, Tyson MD et al (2017) Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years. JAMA 317(11):1126\u20131140","journal-title":"JAMA"},{"issue":"11","key":"4691_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1001\/jama.2017.1652","volume":"317","author":"RC Chen","year":"2017","unstructured":"Chen RC, Basak R, Meyer A-M, Kuo T-M, Carpenter WR, Agans RP et al (2017) Association between choice of radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance and patient-reported quality of life among men with localized prostate cancer. JAMA 317(11):1141\u20131150","journal-title":"JAMA"},{"key":"4691_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ctrv.2018.03.005","volume":"66","author":"M Avila","year":"2018","unstructured":"Avila M, Patel L, Lopez S, Cortes-Sanabria L, Garin O, Pont A et al (2018) Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis. Cancer Treat Rev 66:23\u201344","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"4691_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.eururo.2017.06.035","volume":"72","author":"M Lardas","year":"2017","unstructured":"Lardas M, Liew M, van den Bergh RC, De Santis M, Bellmunt J, Van den Broeck T et al (2017) Quality of life outcomes after primary treatment for clinically localised prostate cancer: a systematic review. Eur Urol 72(6):869\u2013885","journal-title":"Eur Urol"},{"issue":"10","key":"4691_CR11","doi-asserted-by":"publisher","first-page":"331-e7","DOI":"10.1016\/j.urolonc.2024.05.022","volume":"42","author":"T Tiruye","year":"2024","unstructured":"Tiruye T, Beckmann K (2024) Communicating prostate cancer outcomes data to consumers - A brief communication. Urol Oncol: Sem Original Investigations 42(10):331-e7","journal-title":"Urol Oncol: Sem Original Investigations"},{"key":"4691_CR12","first-page":"6660371","volume":"2023","author":"T Tiruye","year":"2023","unstructured":"Tiruye T, Ettridge K, O\u2019Callaghan M, Moretti K, Jay A, Higgs B et al (2023) Reporting real-world data on prostate cancer treatment outcomes to consumers: the prostate cancer report card. Eur J Cancer Care 2023:6660371","journal-title":"Eur J Cancer Care"},{"issue":"1","key":"4691_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eururo.2017.05.055","volume":"73","author":"CJD Wallis","year":"2018","unstructured":"Wallis CJD, Glaser A, Hu JC, Huland H, Lawrentschuk N, Moon D et al (2018) Survival and complications following surgery and radiation for localized prostate cancer: an international collaborative review. Eur Urol 73(1):11\u201320","journal-title":"Eur Urol"},{"issue":"4","key":"4691_CR14","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s11255-024-04304-1","volume":"57","author":"T Tiruye","year":"2025","unstructured":"Tiruye T, Jay A, Higgs B, O\u2019Callaghan M, FitzGerald LM, Moretti K et al (2025) Comparing post-treatment urinary and colorectal procedures in prostate cancer patients using population-based linked data. Int Urol Nephrol 57(4):1189\u20131198","journal-title":"Int Urol Nephrol"},{"issue":"14","key":"4691_CR15","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1056\/NEJMsa0803563","volume":"360","author":"SF Jencks","year":"2009","unstructured":"Jencks SF, Williams MV, Coleman EA (2009) Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 360(14):1418\u20131428","journal-title":"N Engl J Med"},{"key":"4691_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181b13ca2","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al (2009) The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2","journal-title":"Ann Surg"},{"key":"4691_CR17","unstructured":"SA-NT DataLink. (2016) ISAAC Reference Manual: South Australian Admitted Patient Activity Data Standards. In: SA Health, editor. 11 ed. Adelaide, Australia: SA Health."},{"key":"4691_CR18","unstructured":"Australian Bureau of Statistics. (2016) Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, Australia: ABS Website; 2018 [https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/by%20Subject\/2033.0.55.001~2016~Main%20Features~IRSAD~20. Accessed 15 Jul 2021."},{"key":"4691_CR19","unstructured":"Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 5 - Remoteness Structure, July 2016 Canbera, Australia: ABS website; 2018 [https:\/\/bit.ly\/3AfPMEg. Accessed 23 Jun 2022."},{"key":"4691_CR20","unstructured":"Australian Bureau of Statistics (ABS). Country of Birth Standard 2016 [https:\/\/www.abs.gov.au\/statistics\/standards\/country-birth-standard\/latest-release.Accessed Mar 5 2024."},{"key":"4691_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102516","volume":"88","author":"T Tiruye","year":"2024","unstructured":"Tiruye T, Roder D, FitzGerald LM, O\u2019Callaghan M, Moretti K, Beckmann K (2024) Utility of prescription-based comorbidity indices for predicting mortality among Australian men with prostate cancer. Cancer Epidemiol 88:102516","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"4691_CR22","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.clgc.2024.01.018","volume":"22","author":"T Tiruye","year":"2024","unstructured":"Tiruye T, O\u2019Callaghan M, FitzGerald LM, Moretti K, Jay A, Higgs B et al (2024) Medication-based comorbidity measures and prostate cancer treatment selection. Clin Genitourin Cancer 22(2):599\u2013609","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"4691_CR23","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/pros.24750","volume":"84","author":"T Tiruye","year":"2024","unstructured":"Tiruye T, Roder D, FitzGerald LM, O\u2019Callaghan M, Moretti K, Caughey GE et al (2024) Impact of comorbidities on prostate cancer-specific mortality: a population-based cohort study. Prostate 84(12):1138\u20131145","journal-title":"Prostate"},{"key":"4691_CR24","doi-asserted-by":"crossref","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA, et al. (2016) The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. The American Journal of Surgical Pathology. 40(2)","DOI":"10.1097\/PAS.0000000000000530"},{"issue":"9","key":"4691_CR25","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1089\/end.2017.0293","volume":"31","author":"L Xia","year":"2017","unstructured":"Xia L, Taylor BL, Pulido JE, Mucksavage P, Lee DI, Guzzo TJ (2017) Predischarge predictors of readmissions and postdischarge complications in robot-assisted radical prostatectomy. J Endourol 31(9):864\u2013871","journal-title":"J Endourol"},{"issue":"1","key":"4691_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.clgc.2016.06.002","volume":"15","author":"M Moschini","year":"2017","unstructured":"Moschini M, Gandaglia G, Fossati N, Dell\u2019Oglio P, Cucchiara V, Luzzago S et al (2017) Incidence and predictors of 30-day readmission after robot-assisted radical prostatectomy. Clin Genitourin Cancer 15(1):67\u201371","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"4691_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/21681805.2018.1556729","volume":"53","author":"A Wallerstedt Lantz","year":"2019","unstructured":"Wallerstedt Lantz A, Stranne J, Tyritzis SI, Bock D, Wallin D, Nilsson H et al (2019) 90-day readmission after radical prostatectomy\u2014a prospective comparison between robot-assisted and open surgery. Scand J Urol 53(1):26\u201333","journal-title":"Scand J Urol"},{"issue":"1","key":"4691_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.juro.2014.01.109","volume":"192","author":"J\u00d6 Fri\u00f0riksson","year":"2014","unstructured":"Fri\u00f0riksson J\u00d6, Holmberg E, Adolfsson J, Lambe M, Bill-Axelson A, Carlsson S et al (2014) Rehospitalization after radical prostatectomy in a nationwide, population based study. J Urol 192(1):112\u2013119","journal-title":"J Urol"},{"issue":"1","key":"4691_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/bju.16228","volume":"134","author":"NA Soputro","year":"2024","unstructured":"Soputro NA, Chavali JS, Ferguson EL, Ramos-Carpinteyro R, Calvo RS, Nguyen J et al (2024) Complications of single-port robot-assisted radical prostatectomy: multi-institutional analysis from the Single-Port Advanced Research Consortium (SPARC). BJU Int 134(1):54\u201362","journal-title":"BJU Int"},{"issue":"1","key":"4691_CR30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s11701-024-01994-8","volume":"18","author":"A Sakalkale","year":"2024","unstructured":"Sakalkale A, Satheakeerthy S, Yeung JMC, Reid F (2024) Robots down-under: the current climate of robotic-assisted surgery education in Australia. J Robot Surg 18(1):246","journal-title":"J Robot Surg"},{"issue":"6","key":"4691_CR31","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1007\/s11701-023-01714-8","volume":"17","author":"J Wang","year":"2023","unstructured":"Wang J, Hu K, Wang Y, Wu Y, Bao E, Wang J et al (2023) Robot-assisted versus open radical prostatectomy: a systematic review and meta-analysis of prospective studies. J Robot Surg 17(6):2617\u20132631","journal-title":"J Robot Surg"},{"issue":"6","key":"4691_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ans.12097","volume":"84","author":"RM Hall","year":"2014","unstructured":"Hall RM, Linklater N, Coughlin G (2014) Robotic and open radical prostatectomy in the public health sector: cost comparison. ANZ J Surg 84(6):477\u2013480","journal-title":"ANZ J Surg"},{"issue":"4","key":"4691_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/ans.16491","volume":"91","author":"D Trieu","year":"2021","unstructured":"Trieu D, Ju IE, Chang SB, Mungovan SF, Patel MI (2021) Surgeon case volume and continence recovery following radical prostatectomy: a systematic review. ANZ J Surg 91(4):521\u2013529","journal-title":"ANZ J Surg"},{"issue":"1","key":"4691_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.prnil.2022.10.002","volume":"11","author":"S Perera","year":"2023","unstructured":"Perera S, Fernando N, O\u2019Brien J, Murphy D, Lawrentschuk N (2023) Robotic-assisted radical prostatectomy: learning curves and outcomes from an Australian perspective. Prostate Int 11(1):51\u201357","journal-title":"Prostate Int"},{"issue":"3","key":"4691_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.eururo.2018.06.008","volume":"74","author":"A Briganti","year":"2018","unstructured":"Briganti A, Fossati N, Catto JWF, Cornford P, Montorsi F, Mottet N et al (2018) Active surveillance for low-risk prostate cancer: the European association of urology position in 2018. Eur Urol 74(3):357\u2013368","journal-title":"Eur Urol"},{"issue":"4","key":"4691_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/JU.0000000000000031","volume":"201","author":"K Salari","year":"2019","unstructured":"Salari K, Kuppermann D, Preston MA, Dahl DM, Barrisford GW, Efstathiou JA et al (2019) Active surveillance of prostate cancer is a viable option for men younger than 60 years. J Urol 201(4):721\u2013727","journal-title":"J Urol"},{"issue":"7","key":"4691_CR37","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/pros.24502","volume":"83","author":"T Tiruye","year":"2023","unstructured":"Tiruye T, O\u2019Callaghan M, Ettridge K, Jay A, Santoro K, Moretti K et al (2023) Factors impacting on sexual function among men on active surveillance for prostate cancer. Prostate 83(7):678\u2013687","journal-title":"Prostate"},{"key":"4691_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2023.102482","volume":"87","author":"T Tiruye","year":"2023","unstructured":"Tiruye T, Roder D, FitzGerald LM, O\u2019Callaghan M, Moretti K, Beckmann K (2023) Prognostic value of comorbidity measures among Australian men with non-metastatic prostate cancer. Cancer Epidemiol 87:102482","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"4691_CR39","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1038\/s41598-023-45856-z","volume":"13","author":"T Tiruye","year":"2023","unstructured":"Tiruye T, David R, O\u2019Callaghan M, FitzGerald LM, Higgs B, Kahokehr AA et al (2023) Risk of secondary malignancy following radiation therapy for prostate cancer. Sci Rep 13(1):20083","journal-title":"Sci Rep"},{"issue":"7","key":"4691_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/pon.6369","volume":"33","author":"T Tiruye","year":"2024","unstructured":"Tiruye T, Hiwase M, Charlick M, O\u2019Callaghan M, Khalid A, Li M et al (2024) Temporal trends in medication and service use patterns for mental health issues among men with prostate cancer. Psycho-Oncol 33(7):e6369","journal-title":"Psycho-Oncol"},{"key":"4691_CR41","unstructured":"Lix LM, Smith M, Pitz M, Ahmed R, Quon H, Griffith J, et al. (2016) Cancer data linkage in Manitoba: expanding the infrastructure for research: Manitoba Centre for Health Policy, College of Medicine, Faculty of Health."}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04691-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04691-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04691-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:21:36Z","timestamp":1770042096000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04691-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4691"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04691-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}